CERVICAL cancer is the fourth most common cancer in Jamaica, and the second leading cause of cancer-related deaths among Jamaican women. But it is considered a preventable disease, and ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

Cervical screening appointments take no more than ten minutes. Unfortunately, for many, they're a cause of worry. While millions of people attend these appointments each year, some miss out on the ...

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with progressive cervical cancer and the toxicity profile of tisotumab vedotin. WESTIN: ...